General Ledger Accounts Assistant
We are currently recruiting for an experienced General Ledger Accounts Assistant on a 6 month Fixed Term Contract, to join our team based in Abingdon (Oxfordshire). The successful candidate much have previous General Ledger experience.
Role: General Ledger Accounts Assistant Role Type: 6 Month Fixed Term Contract Salary: Competitive salary, plus excellent company benefits Hours: Full time, 40 hours per week, Monday to Friday Location: Hybrid, Abingdon, Oxfordshire Our Company Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic.
In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology, inflammation and metabolic diseases.
Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies Main Responsibilities will include Processing of local and foreign payments Allocation of cash receipts and payments against sales and purchase ledgers, including month end reconciliations and revaluations of these accounts Processing and controlling of fixed asset accounting and the month end reconciliations of these accounts Monitoring and controlling month end accruals and prepayments and ensuring complete reconciliation processes are in place Examine and track intercompany recharges Review and post credit card and travel transactions Prepare VAT return Journal entry postings Review and post intercompany recharges Assist with year end statutory financial statements Assist with R&D tax credits calculations and submission of claim Prepare month end balance sheet reconciliations Assist with cashflow forecasting Adhere to SOX controls compliance Company Benefits Pension on completion of (but not subject to) your 3-month probationary period.
Contributions 6% for employees (salary sacrifice) and 6% for the employer. The employee can opt to increase their contribution, and the employer will match the increase up to a maximum of 7.5%. 25 days holiday plus bank holidays and additional length of service days awarded on the 1 year anniversary, up to a maximum of 30 days. Private health insurance with BUPA for the employees and their partner/family under the company scheme.
Private dental cover, after 3 months of service. Life assurance at four times your annual base salary. Well being support 24/7 and counselling services. Permanent health insurance provides 75% of the base salary after the qualifying period. Cycle-to-work scheme. Refer a friend scheme, recognition awards and many more!
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap. EN: In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
IT: In compliance with fundamental ethical and professional principles and with Legislative Decree 198/2006, Evotec is an Equal Opportunity Employer committed to fostering a safe, diverse, and inclusive workplace built on mutual respect. We provide equal employment opportunities to all qualified candidates and employees based on their skills, experience, and professional qualifications.
In line with our ethical and professional principles, all employment-related decisions, including recruitment and selection processes, are made fairly and without any form of discrimination.
All qualified candidates will be considered for employment regardless of race, color, sex, age, disability, genetic information, gender expression, gender identity, nationality, religion, sexual orientation, or any other characteristic protected under applicable law.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products.
Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people.
The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn. Please click on the link below to access and review our Privacy Information for Applicants: Privacy Information for Applicants
